Bicycle Therapeutics plc (BCYC) Operating margin 2017–2025
Bicycle Therapeutics plc (BCYC) operating margin by fiscal year — reported operating income divided by reported revenue.
-340.4%FY2025 · since FY2017: -787.0% → -340.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -340.4% | +254.6 pp |
| FY2024 | -595.0% | +109.2 pp |
| FY2023 | -704.1% | +102.4 pp |
| FY2022 | -806.6% | -245.6 pp |
| FY2021 | -561.0% | -60.9 pp |
| FY2020 | -500.1% | -309.5 pp |
| FY2019 | -190.6% | +114.2 pp |
| FY2018 | -304.7% | +482.3 pp |
| FY2017 | -787.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCYC financial trends
BCYC RevenueBCYC Net incomeBCYC Net marginBCYC Gross profitBCYC Gross marginBCYC Operating incomeBCYC Operating cash flowBCYC Free cash flowBCYC Capital expendituresBCYC Return on equityBCYC Stock buybacksBCYC Dividends paidBCYC Total assetsBCYC Total liabilitiesBCYC Shareholders’ equityBCYC overview →